ReNerve Strengthens Growth with Empliq Portfolio Launch in Global Tissue Repair Markets.

ReNerve Ltd (ASX: RNV) is advancing its mission to transform nerve repair and tissue regeneration through science with the launch of its Empliq product portfolio, complementing its established NervAlign range. Surgeons who use NervAlign products for nerve repair often utilize dermal and amniotic membranes in broader reconstructive procedures, providing ReNerve with a natural growth pathway into adjacent high-demand markets. The Empliq range, including AmnioLite, AmnioDuo, Placental, and Dermal matrices, is designed to protect healing tissue, reduce scarring, and enable faster regeneration across applications such as diabetic foot ulcers, venous leg ulcers, surgical wounds, breast reconstruction, tendon augmentation, and hernia repair.

Supported by its partnership with Berkeley Biologics, a global multi-service tissue bank, ReNerve ensures high-quality allografts with scalable production and regulatory compliance in the US. With first sales achieved and market approvals secured, the Empliq portfolio strengthens ReNerve’s distribution network and opens significant revenue opportunities in the global dermal and amniotic tissue repair markets projected to grow strongly through 2032.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com